DJ Innate Pharma Is Maintained at Market Perform by SVB Leerink
Ratings actions from Benzinga: https://www.benzinga.com/stock/IPHA/ratings
(END) Dow Jones Newswires
March 19, 2021 06:30 ET (10:30 GMT)
DJ Innate Pharma Price Target Raised to $7.00/Share From $5.00 by SVB Leerink
Ratings actions from Benzinga: https://www.benzinga.com/stock/IPHA/ratings
(END) Dow Jones Newswires
March 19, 2021 06:30 ET (10:30 GMT)